Real-world effectiveness of a new injection for advanced lymphoma

This study is following about 700 adults across multiple countries to see how well epcoritamab works in real-world settings for people with advanced lymphoma. Epcoritamab is a new medication given as an injection under the skin. The study will track participants for up to 3 years to understand how this medication helps patients whose lymphoma has not responded well to earlier treatments.

While this medication has shown promise in earlier testing, doctors need to understand how well it actually works when used in routine clinical practice across different countries and patient populations. This real-world evidence helps ensure the treatment is truly helpful for patients like you.